Oculis' eye drug meets main goal in study
(Repeats to widen distribution with no changes to text)
May 22 (Reuters) - Oculis Holding OCS.O on Monday said
its drug to treat a type of eye disorder met its main goal in a
late-stage study.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Janane
Venkatraman)
((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91
9873062788;))